Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Expression of hpttg proto-oncogene in lymphoid neoplasias

Abstract

Pituitary tumor-transforming gene (pttg) is a distinct proto-oncogene which is expressed in certain normal tissues with high proliferation rate and in a variety of tumors. PTTG is the vertebrate analog of yeast securins Pds1 and Cut2 with a key role in the regulation of sister chromatid separation during mitosis. Impairment of PTTG regulated functions is expected to lead to chromosomal instability and aneuploidy. Human pttg (hpttg) is abundantly expressed in Jurkat T lymphoblastic lymphoma cells but not in normal peripheral blood leukocytes. To obtain additional data on the potential role of hpttg in lymphomagenesis we selected 150 cases of lymphoid tumors for the assessment of hpttg expression in tumor tissues. Immunohistochemical studies on formalin-fixed, paraffin-embedded tissues revealed hPTTG in 38.8% of B-cell lymphomas, 70.2% of T-cell lymphomas, and 73.1% of Hodgkin's lymphomas. Among B-cell lymphomas, the most frequently immunostained tumors were plasma cell tumors, diffuse large cell lymphomas, and follicle center cell lymphomas. In Hodgkin's disease, immunoreactivity was mainly noted in Reed-Sternberg cells. In conclusion, the frequent overexpression of hpttg in many histological subtypes of lymphoma suggests the involvement of this proto-oncogene in lymphomagenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B . 1998 Nature 392: 300–303

  • Chien W, Pei L . 2000 J. Biol. Chem. 275: 19422–19427

  • Cohen-Fix O, Koshland D . 1997 Proc. Natl. Acad. Sci. USA. 94: 14361–14366

  • Cory S . 1986 Adv. Cancer Res. 47: 189–234

  • Dasika GK, Lin SCJ, Zhao S, Sung P, Tomkinson A, Lee EYHP . 1999 Oncogene 18: 7883–7899

  • Davies J, Badiani P, Weston K . 1999 Oncogene 18: 3643–3647

  • Domínguez A, Ramos-Morales F, Romero F, Rios RM, Dreyfus F, Tortolero M, Pintor-Toro JA . 1998 Oncogene 17: 2187–2193

  • Hardwick KG . 1998 Trends Genet. 14: 1–4

  • Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA . 1994 Blood 84: 1361–1392

  • Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M, Melmed S . 2000 Lancet 355: 716–719

  • Hecht JL, Aster JC . 2000 J. Clin. Oncol. 18: 3707–3721

  • Jallepalli PV, Waizenegger IC, Bunz F, Langer S, Speicher MR, Peters JM, Kinzler KW, Vogelstein B, Lengauer C . 2001 Cell 105: 445–457

  • Jin S, Weaver DT . 1997 EMBO J. 16: 6874–6885

  • King RW, Glotzer M, Kirschner MW . 1996 Mol. Biol. Cell. 7: 1343–1357

  • Landanyi M, Offit K, Jhanwar SC, Filippa DA, Chaganti RSK . 1991 Blood 77: 1057–1063

  • Lengauer C, Kinzler KW, Vogelstein B . 1998 Nature 396: 643–649

  • Li GC, Ouyang H, Li X, Nagasawa H, Little JB, Chen DJ, Ling CC, Fuks Z, Cordon-Cardo C . 1998 Mol. Cell. 2: 1–8

  • Marcu KB, Bossone SA, Patel AJ . 1992 Annu. Rev. Biochem. 61: 809–860

  • Pei L . 2001 J. Biol. Chem. 276: 8484–8491

  • Pei L, Melmed S . 1997 Mol. Endocrinol. 11: 433–441

  • Rabbits TH . 1994 Nature 372: 143–149

  • Ramos-Morales F, Domínguez A, Romero F, Luna R, Multon MC, Pintor-Toro JA, Tortolero M . 2000 Oncogene 19: 403–409

  • Rao PH, Houldsworth J, Dyomina K, Parsa NZ, Cigudosa JC, Louie DC, Popplewell L, Offit K, Jhanwar SC, Chaganti RS . 1998 Blood 92: 234–240

  • Romero F, Multon MC, Ramos-Morales F, Domínguez A, Bernal JA, Pintor-Toro JA, Tortolero M . 2001 Nucleic Acids Res. 29: 1300–1307

  • Sáez C, Japón MA, Ramos-Morales F, Romero F, Segura DI, Tortolero M, Pintor-Toro JA . 1999 Oncogene 18: 5473–5476

  • Strausberg RL, Dahl CA, Klausner RD . 1997 Nat. Genet. 15: 415–416

  • Werner CA, Döhner H, Joos S, Trümper LH, Baudis M, Barth TFE, Ott G, Möller P, Lichter P, Bentz M . 1997 Am. J. Pathol. 151: 335–342

  • Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S . 1999a J. Clin. Endocrinol. Metab. 84: 761–767

  • Zhang X, Horwitz GA, Prezant TR, Valentini A, Nakashima M, Bronstein MD, Melmed S . 1999b Mol. Endocrinol. 13: 156–166

  • Zou H, McGarry TJ, Bernal T, Kirschner MW . 1999 Science 285: 418–422

Download references

Acknowledgements

This work has been supported by grants from Ministerio de Educación y Cultura, Spain (SAF99-0125-C03); Dirección General de Universidades e Investigación, Junta de Andalucía; and Fundación Andex.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carmen Sáez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sáez, C., Pereda, T., Borrero, J. et al. Expression of hpttg proto-oncogene in lymphoid neoplasias. Oncogene 21, 8173–8177 (2002). https://doi.org/10.1038/sj.onc.1205954

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205954

Keywords

This article is cited by

Search

Quick links